Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Optinose Inc (OPTN)

Optinose Inc (OPTN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 60,662
  • Shares Outstanding, K 10,060
  • Annual Sales, $ 70,990 K
  • Annual Income, $ -35,480 K
  • EBIT $ -19 M
  • EBITDA $ -17 M
  • 60-Month Beta -0.15
  • Price/Sales 0.74
  • Price/Cash Flow N/A
  • Price/Book N/A

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate -0.67
  • Number of Estimates 2
  • High Estimate -0.60
  • Low Estimate -0.75
  • Prior Year -1.35
  • Growth Rate Est. (year over year) +50.37%

Price Performance

See More
Period Period Low Period High Performance
1-Month
4.93 +29.41%
on 01/14/25
7.20 -11.39%
on 12/18/24
-0.48 (-6.95%)
since 12/17/24
3-Month
4.82 +32.50%
on 11/20/24
12.15 -47.49%
on 10/28/24
-4.87 (-43.29%)
since 10/17/24
52-Week
4.82 +32.50%
on 11/20/24
31.50 -79.75%
on 03/18/24
-13.12 (-67.28%)
since 01/17/24

Most Recent Stories

More News
Optinose Announces Preliminary Unaudited Fourth Quarter 2024 XHANCE Net Revenue of $22.4 Million

OPTN : 6.38 (+5.80%)
Optinose Announces 1-for-15 Reverse Stock Split

OPTN : 6.38 (+5.80%)
Optinose to Present at the Piper Sandler 36th Annual Healthcare Conference

OPTN : 6.38 (+5.80%)
Optinose Reports Third Quarter 2024 Financial Results and Recent Operational Highlights

OPTN : 6.38 (+5.80%)
Optinose Announces Reporting Date for Third Quarter 2024 Financial Results

OPTN : 6.38 (+5.80%)
Optinose Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

OPTN : 6.38 (+5.80%)
Optinose Appoints Terry Kohler as Chief Financial Officer

OPTN : 6.38 (+5.80%)
OptiNose: Q2 Earnings Snapshot

OptiNose: Q2 Earnings Snapshot

OPTN : 6.38 (+5.80%)
OptiNose: Q1 Earnings Snapshot

OptiNose: Q1 Earnings Snapshot

OPTN : 6.38 (+5.80%)
OptiNose: Q4 Earnings Snapshot

OptiNose: Q4 Earnings Snapshot

OPTN : 6.38 (+5.80%)

Business Summary

OptiNose Inc. is a specialty pharmaceutical company. It focused on the development and commercialization of products for patients treated by ear, nose and throat or ENT and allergy specialists. The company's lead product consists of XHANCE nasal polyps, XHANCE Chronic sinusitis, OPN-300, OPN- 021 and...

See More

Key Turning Points

3rd Resistance Point 7.32
2nd Resistance Point 6.99
1st Resistance Point 6.68
Last Price 6.38
1st Support Level 6.04
2nd Support Level 5.71
3rd Support Level 5.40

See More

52-Week High 31.50
Fibonacci 61.8% 21.31
Fibonacci 50% 18.16
Fibonacci 38.2% 15.01
Last Price 6.38
52-Week Low 4.82

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar